Low Nonrelapse Mortality and Prolonged Long-Term Survival after Reduced-Intensity Allogeneic Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B Cell Lymphoma: Report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire-Reference-Cited by-同舟云学术

Low Nonrelapse Mortality and Prolonged Long-Term Survival after Reduced-Intensity Allogeneic Stem Cell Transplantation for Relapsed or Refractory Diffuse Large B Cell Lymphoma: Report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire

Published:2010-01 Issue:1 Volume:16 Page:78-85
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Sirvent Anne,Dhedin Nathalie,Michallet Mauricette,Mounier Nicolas,Faucher Catherine,Yakoub-Agha Ibrahim,Mohty Mohamad,Robin Marie,Tabrizi Reza,Clement Laurence,Bilger Karin,Larosa Fabrice,Contentin Nathalie,Huyn Anne,François Sylvie,Bulabois Claude-Eric,Ceballos Patrice,Bourrhis Jean-Henri,Buzyn Agnès,Cornillon Jérôme,Guillerm Gaelle,de Revel Thierry,Bay Jacques-Olivier,Guilhot François,Milpied Noël

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference39 articles.

1. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma;Coiffier;N Engl J Med,2002

2. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non Hodgkin's lymphoma;Philip;N Engl J Med,1995

3. BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma;Mills;J Clin Oncol,1995

4. R-ICE versus DHAP in relapsed patients with diffuse large B-cell lymphoma (DLBCL) followed by stem cell transplantation and maintenance treatment with Rituximab or not: first interim analysis on 200 patients. CORAL study;Gisselbrecht;Blood,2007

5. Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma;Hamlin;Blood,2003

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic stem cell transplantation and CAR-T in B-cell Non-Hodgkin Lymphoma: a two-center experience and review of the literature;Annals of Hematology;2024-03-02

2. CURRENT SITUATION AND FUTURE ISSUES OF MSC AND CAR-T CELL THERAPY;Japanese Journal of Transfusion and Cell Therapy;2024-02-26

3. Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

4. Therapeutic options for large B-cell lymphoma relapsing after CD19-directed CAR T-cell therapy;Bone Marrow Transplantation;2023-12-16

5. Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma;Bone Marrow Transplantation;2023-12-15